- Report
- June 2023
- 200 Pages
Global
From €4719EUR$4,950USD£4,022GBP
- Report
- May 2024
- 195 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- June 2024
- 89 Pages
Global
From €5339EUR$5,600USD£4,551GBP
- Report
- February 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- June 2024
- 421 Pages
Global
From €6669EUR$6,995USD£5,684GBP
- Report
- March 2024
- 199 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- March 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- May 2024
- 185 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- October 2023
- 188 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1907EUR$2,000USD£1,625GBP
- Report
- January 2024
- 120 Pages
Global
From €7579EUR$7,950USD£6,460GBP
- Report
- February 2024
- 114 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Report
- May 2024
- 250 Pages
Global
From €3809EUR$3,995USD£3,246GBP
- Report
- May 2024
- 500 Pages
Global
From €3809EUR$3,995USD£3,246GBP
- Report
- May 2024
- 250 Pages
Global
From €3809EUR$3,995USD£3,246GBP
- Report
- May 2024
- 500 Pages
Global
From €3809EUR$3,995USD£3,246GBP
- Report
- March 2024
- 580 Pages
Global
From €6669EUR$6,995USD£5,684GBP
- Report
- June 2024
- 642 Pages
Global
From €6669EUR$6,995USD£5,684GBP
- Report
- June 2024
- 352 Pages
Global
From €6669EUR$6,995USD£5,684GBP
- Report
- May 2024
- 640 Pages
Global
From €4575EUR$4,799USD£3,900GBP
The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more